1. Introduction {#sec1}
===============

Coronary artery disease (CAD) is currently the most common, noncommunicable disease in India, affecting over 65 million people. CAD is a major cause of morbidity and mortality in India. Approximately, 8--10% of Indians in urban areas and 3--4% in rural areas have CAD.[@bib1] CAD tends to occur at a younger age in Indians, with more extensive angiographic involvement contributed by genetic, metabolic, conventional and nonconventional risk factors.[@bib2]^,^[@bib3]

Primary percutaneous coronary intervention (PPCI) is the treatment of choice in ST-elevation myocardial infarction (STEMI), as in comparison with thrombolysis, PPCI guarantees a higher rate of reperfusion. However, in patients presenting late it does not prevent complete myocardial necrosis, which is related to the duration of occlusion, particularly in higher-risk patients.

The present study attempts to describe the correlation between arterial and intracoronary blood values (pH, bicarbonate, lactate levels, partial pressures of carbon dioxide (pCO~2~) and oxygen (pO~2~) in patients of STEMI undergoing PPCI and also whether these parameters correlate with clinical data and short-term outcome of the patients.

2. Methods {#sec2}
==========

2.1. Study design {#sec2.1}
-----------------

We performed a single-centre, prospective study over a period of 12 months conducted in Department of Cardiology, Dayanand Medical College and Hospital, Unit-Hero DMC Heart Institute, Ludhiana. All patients of STEMI presenting in emergency and undergoing PPCI and in whom adequate intracoronary sample could be obtained were included in the study.

2.2. Study population {#sec2.2}
---------------------

Patients with STEMI who were referred for PPCI within 12 h after the onset of symptoms, in whom adequate intracoronary arterial sample could be obtained were eligible to participate in the trial. All patients provided written informed consent. Patients with chronic kidney disease, chronic liver disease and patients who had received fibrinolytic therapy were not eligible.

2.3. Procedure and laboratory methods {#sec2.3}
-------------------------------------

Patients underwent the procedure according to the operator\'s usual technique. After cannulating the involved coronary artery by guiding catheter, the lesion was crossed with a guidewire and the Export (Medtronic) aspiration catheter was advanced and suction started before it crossed the lesion. The first intracoronary blood suctioned was sent for arterial blood gas (ABG) analysis. It was made sure that the guide catheter be fully engaged with the coronary ostium during removal of the aspiration catheter to avoid embolizing thrombus to the systemic vasculature. The percutaneous coronary intervention procedure was performed after aspiration was completed. At the very same time, blood from peripheral artery was also sent for ABG analysis. ABG analysis was performed by using instrument, GEM Premier 3000. Heparinized 2 ml of Intracoronary and peripheral blood sample was used for analysis. Parameters analysed included pH, lactate, bicarbonate levels and partial pressures of carbon dioxide (pCO~2~) and oxygen (pO~2~).

2.4. Study outcomes {#sec2.4}
-------------------

Intracoronary and peripheral ABG samples were compared among themselves for analysed parameters and in addition, intracoronary blood parameters were also correlated with clinical data, investigational data and short-term (30-day) outcome.

2.5. Statistical analysis {#sec2.5}
-------------------------

Categorical variables were presented as numbers and percentage, continuous variables as mean ± standard deviation (SD) or median and 95% confidence interval (95% CI). Comparisons were made using the Student\'s *t*-test for numerical parameters and the chi-squared test for categorical data where appropriate. Categorical variables were compared by chi-squared analysis. Continuous variables were compared by Student\'s *t*-test. A *p*-value of \<0.05 was considered to be statistically significant. All the data were recorded on Microsoft Excel database and statistical analysis was performed using SPSS software (version 23.0, SPSS Inc., Chicago, Illinois, USA).

3. Results {#sec3}
==========

The study involved a total of 27 STEMI patients. The baseline characteristics of the study population are listed in [Table 1](#tbl1){ref-type="table"}. The average symptom duration to door time was 162 min and average door to balloon time was 27.5 min. There were 4 patients with Killip class ≥II. Anterior infarct was seen in 77% and 23% had inferior infarction. Intra-aortic balloon pump was used in single patient (3.7%). Coronary angiogram revealed single-vessel disease in 66% of subjects. Double-vessel disease was present in 26% of subjects and 8% had triple-vessel disease. Diabetes and hypertension were seen in 26% of subjects. Dyslipidaemia was present in 66%, 22% were obese and 11% were smokers. No patient in our study population died or had 30-day readmission or revascularization.Table 1Baseline characteristics and key time intervals (*N* = 27).Table 1ParameterTotal (*N* = 27)Age (y)54.8 ± 9.4Males (*n* and %)21 (77%)Symptom duration to door (min)162 ± 72Door to balloon (min)27.5 ± 9Killip class ≥ II (*n* and %)4 (15%)HR (bpm)82 ± 15SBP (mm Hg)125 ± 15DBP (mm Hg)76 ± 11BMI (kg/m^2^)27.2 ± 4.8Infarct location Anterior (*n* and %)21 (77.7%) Inferior (*n* and %)6 (22.3%)Vessel involved LAD21 (77.7%) LCX1 (3.7%) RCA5 (18.5%)Haemoglobin (gm%)14 ± 1.9Urea (mg/dl)27.7 ± 6.7Creatinine (mmol/l)0.85 ± 0.16eGFR (ml/min per 1.73 m^2^)SGOT (IU/l)87 ± 116SGPT (IU/l)37 ± 18Lipid profile TC (mg/dl)206 ± 57 LDL (mg/dl)143 ± 50 TG (mg/dl)177 ± 93 HDL (mg/dl)38 ± 8LVEF (%)38 ± 4[^1][^2]

Serum markers of metabolic acidosis are often used as a part of critical care assessment to determine the severity of injury and provide prognostic information. The most common of these markers include lactate, bicarbonate and pH. On comparing intracoronary and peripheral blood **(**[Table 2](#tbl2){ref-type="table"}**)**, our results revealed nearly correlating pH (95% CI −0.01 to 0.02; *p* = 0.44), lactate (95% CI 0.03--0.1; *p* = 0.28), bicarbonate (95% CI 0.6--1.5; *p* = 0.64), pCO~2~ (95% CI 1.1--2.4; *p* = 0.79) and pO~2~ (95% CI 3.2--47.5; *p* = 0.06).Table 2Comparison of intracoronary and peripheral blood.Table 2VariableIntracoronary blood (mean ± SD)Peripheral blood (mean ± SD)95% CI*p*-ValuepH7.37 ± 0.057.37 ± 0.06−0.01 to 0.020.44Lactate (meq/l)1.63 ± 0.791.73 ± 1.160.03--0.10.28Bicarbonate (meq/l)21.60 ± 3.021.42 ± 3.10.6--1.50.64pCO~2~ (mm Hg)37.26 ± 5.737.48 ± 6.41.1--2.40.79pO~2~ (mm Hg)117.04 ± 39.3140.85 ± 64.33.2--47.50.06[^3]

Intracoronary lactate levels ([Table 3](#tbl3){ref-type="table"}) were found to be significantly higher in patients with more symptom onset to door time (*p* = 0.025) **(**[Fig. 1](#fig1){ref-type="fig"}**)**. Systolic blood pressure (SBP; *p* = 0.03) was also significantly lower in subjects with increasing lactate levels. Hyperlactatemia did not show association with estimated glomerular filtration rate (eGFR; *p* = 0.93), Killip class (*p* = 0.38) or left ventricular ejection fraction (LVEF; *p* = 0.56). As there was no mortality or short-term readmission or revascularization, the significance of these parameters could not be assessed. Intracoronary pH showed no association with symptom onset to door time, systolic blood pressure, eGFR, Killip class or LVEF.Table 3Parameters according to intracoronary lactate levels.Table 3Intracoronary lactate≤2 meq/l (*n* = 20)\>2 meq/l (*n* = 7)*p*-ValueSymptom to door time (min)140 ± 58224 ± 750.025SBP (mm Hg)128 ± 13114 ± 170.03DBP (mm Hg)79 ± 970 ± 110.08Killip classI1850.38≥II22LVEF (%)38 ± 437 ± 20.56eGFR (ml/min per 1.73 m^2^)104 ± 26105 ± 320.37[^4]Fig. 1Boxplot showing relationship of IC-lactate levels and symptom onset to door time. IC, intracoronary.Fig. 1

4. Discussion {#sec4}
=============

Limited information is available on acid--base disturbances in the course of myocardial infarction; and at present, there is no study to the best of knowledge have compared the intracoronary and peripheral blood in patients of STEMI undergoing PPCI.

The hypothesis was that because of stasis of blood in culprit intracoronary artery, it has lower pH and bicarbonate, more deoxygenated blood and higher lactate levels, and whether it will help to provide more clinical information and prognostication than the information given solely by peripheral blood.

The acid--base balance provides clinical information and is useful for in-hospital risk stratification in STEMI patients because the detection of acidosis characterizes patients with a more severe myocardial dysfunction who therefore have higher morbidity and mortality.

In our study, it was seen that the blood from culprit intracoronary vessel was no different when compared to peripheral blood and none of the parameters of the two samples, like pH, bicarbonate, lactate, partial pressures of carbon dioxide and oxygen reached statistical significance. Because of absence of literature on intracoronary blood in STEMI, our findings could not be correlated with any of the previous studies.

Intracoronary hyperlactatemia was present in patients presenting with higher symptom onset to door times, also these patients had lower systolic blood pressure on presentation. However, pH of intracoronary blood, when compared with clinical and investigational parameters, was not significant with any parameter.

The prognostic significance of lactate in acute coronary syndrome has been investigated in observational, mainly single-centre studies.[@bib4]^,^[@bib5] Lactate concentrations, measured in the early phase of STEMI are influenced by the degree of hemodynamic impairment (as indicated by Killip class) and myocardial ischemia (as inferred by Troponin I). In 1176 STEMI patients, hyperlactatemia measured at arrival in the catheterization laboratory was associated with worse outcome measures[@bib6] (increased 30-d mortality, larger enzymatic infarct size and increased use of intra-aortic balloon pump\]. In 807 STEMI patients treated with percutaneous coronary intervention, lactate values were independently associated with early mortality only in the subgroup of patients in advanced Killip class.[@bib7]

MacKenzie et al[@bib8] observed that patients with cardiogenic shock complicating myocardial infarction show significant metabolic acidosis and a poor prognosis. Pilcher and Nagle[@bib9] documented that there was no relationship between acid--base status (assessed by pH) and ventricular dysrhythmias in myocardial infarction without cardiogenic shock. In both these studies, patients with an acute myocardial infarction were medically treated. In a small study by Gandhi and Akholkar[@bib10], on 50 patients of STEMI and the use of thrombolytic therapy, mortality in patients with pH level \<7.35 was 60% in those with pH level more than 7.45 was 11.11% (*p* = 0.03). In above studies, parameters of peripheral blood gas analysis were used, but our study used intracoronary blood.

Results of our small, single-centre study showed that no extra prognostic information can be obtained from intracoronary blood when compared with peripheral blood. Hyperlactatemia, however, was more in patients presenting late after symptom onset, and systolic blood pressure on presentation was also significantly lower in such patients.

In-hospital mortality and short-term outcome could not be evaluated as an outcome because none of our patients had in-hospital mortality or had 30-day readmission or revascularization. Although this finding is not surprising as our study population was small, it would be interesting to evaluate in a larger cohort of patients, where intracoronary blood analysis might hold a prognostic role.

We acknowledge several limitations in our study. First, this study comprises small sample size. Second, patients in whom adequate intracoronary sample could not be obtained were excluded from the study, so not all STEMI patients were included. Third, for the analysis of intracoronary blood, crossing the occluded coronary artery with a guidewire may result in partial restoration of epicardial blood flow. This may result in changes of the local metabolites and thus the results. Fourth, in-hospital mortality and short-term (30-day) outcome could not be evaluated as an outcome because of the absence of mortality and readmission or revascularization in our population.

5. Conclusions {#sec5}
==============

We did this study with the premise that parameters like acidosis, hyperlactatemia and hypoxia will be more in the intracoronary blood of the culprit vessel as compared with peripheral blood in patients undergoing PPCI for STEMI. The results of our study showed that the evaluation of intracoronary blood provides no additional information regarding the prognosis and short-term (30-day) outcome of the patients when compared with peripheral blood. However, there was a significant intracoronary hyperlactatemia in patients presenting late after symptom onset. SBP was also significantly less in patients with high intracoronary lactate, which signifies that predominant cause of hyperlactatemia is systemic hypoperfusion rather than local increase in lactate levels.
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[^1]: All values are presented as mean ± SD or number (%).

[^2]: SD, standard deviation; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; LAD, left anterior descending; LCX, left circumflex; RCA, right coronary artery; eGFR, estimated glomerular filtration rate; SGOT, serum glutamic\--oxaloacetic transaminase; SGPT, serum alanine aminotransferase; TC, total cholesterol; LDL, low-density lipoprotein; TG, triglycerides; HDL: high-density lipoprotein; LVEF, left ventricle ejection fraction.

[^3]: CI, confidence interval; SD, standard deviation; pCO~2~, partial pressure of CO~2~; pO~2~, partial pressure of O~2~.

[^4]: SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEF, left ventricle ejection fraction; eGFR, estimated glomerular filtration rate.
